Study Evaluating Etanercept in Patients With Rheumatoid Arthritis(RA), Juvenile Idiopathic Arthritis (JIA), or Psoriatic Arthritis (PsA) in Spain

Evaluating Safety and QoL in Patients Treated With Etanercept: an Open Multicenter Study

The purpose of this study is to assess the safety of etanercept in patients with rheumatoid arthritis (RA), juvenile idiopathic arthritis (JIA) or psoriatic arthritis (PsA) in Spain

Inclusion Criteria:

• RA or PsA in whom DMARDs/antiTNF antibodies/anti IL1 has been insufficient or inappropriate
• Children from 4 to 17 years old with JIA polyarticular

Exclusion Criteria:

• Clinically significant abnormal screening lab values
• Patients who are planning to undergo elective surgery during the study period.
• Other current autoimmune connective tissue diseases